2025 Extended clinical phenotypes and treatment modalities in 32 JAGN1-deficient patients: a multicenter study by ESID and EBMT IEWP Group Inborn Errors Working Party (IEWP) Other society 1st listed author Julia Fekadu-Siebald Journal Blood Adv.
2025 HLA-haploidentical stem cell transplantation for chronic granulomatous disease: an EBMT-IEWP retrospective study Group Inborn Errors Working Party (IEWP) 1st listed author Quentin Riller Journal Blood.
2025 Defining Bloodstream and Central Venous Catheter-Related Infections in Patients Following Haematopoietic Cell Transplantation: Position Paper of the EBMT Infectious Diseases Working Party and Practice Harmonization and Guidelines Committee Group Infectious Diseases Working Party (IDWP) Practice Harmonisation and Guidelines Committee 1st listed author Dina Averbuch Journal Clin Microbiol Infect.
2025 Aggressive MS and Autologous HSCT: A review on behalf of the Autoimmune Diseases Working Party of the European Society for Blood and Marrow Transplantation Group Autoimmune Diseases Working Party (ADWP) 1st listed author Giacomo Boffa Journal Mult Scler.
2025 Hematopoietic stem cell transplantation is effective in achieving long-term survival for post-aplastic anemia myeloid neoplasms: the EBMT Severe Aplastic Anemia Report Group Severe Aplastic Anaemia Working Party (SAAWP) 1st listed author Pedro Henrique Prata Journal Haematologica.
2025 Global paediatric haematopoietic stem-cell transplantation training and access: providing strategies to overcome challenges Group Trainee Committee 1st listed author Candice Laverne Hendricks Journal Lancet Haematol.
2025 Impact of fludarabine dose on outcome after allo-HSCT with reduced intensity conditioning for older patients with AML Group Acute Leukemia Working Party (ALWP) 1st listed author Guillaume Dachy Journal Bone Marrow Transplant.
2025 Less frequent complications following CAR T-cell therapies: hemophagocytic lymphohistiocytosis, graft-versus-host disease, thrombotic microangiopathy, coagulation disorders and secondary malignancies: best practice recommendations from the EBMT Practice Harmonization and Guidelines Committee Group Transplant Complications Working Party (TCWP) Practice Harmonisation and Guidelines Committee 1st listed author Guillermo Ortí Journal Bone Marrow Transplant.
2025 Daratumumab for PRCA after HCT: study and practical considerations from the EBMT Transplant Complications Working Party Group Transplant Complications Working Party (TCWP) 1st listed author Nico Gagelmann Journal Blood Cancer J.
2025 Prognostic significance of cytogenetic risk score in patients with secondary acute myeloid leukemia undergoing allogeneic stem cell transplantation from HLA-matched unrelated donors: a study from the ALWP /EBMT Group Acute Leukemia Working Party (ALWP) 1st listed author Arnon Nagler Journal Bone Marrow Transplant.
2025 Post-pandemic recommendations for the management of COVID-19 in patients with haematological malignancies or undergoing cellular therapy, from the European Conference on Infections in Leukaemia (ECIL-10) Group Infectious Diseases Working Party (IDWP) 1st listed author Simone Cesaro Journal Leukemia.
2025 Clinical characteristic and outcome of HHV-6 encephalitis after allogeneic hematopoietic cell transplantation: A study of Infectious Disease Working Party of EBMT Group Infectious Diseases Working Party (IDWP) 1st listed author Katia Perruccio Journal Bone Marrow Transplant.